Bryan Supran
Direktor/Vorstandsmitglied bei ANACOR PHARMACEUTICALS INC
Vermögen: 212 553 $ am 30.04.2024
Aktive Positionen von Bryan Supran
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANACOR PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 24.06.2016 | - |
HALEON PLC | Direktor/Vorstandsmitglied | 18.07.2022 | - |
PFIZER, INC. | General Counsel | 01.04.2016 | - |
Karriereverlauf von Bryan Supran
Ehemalige bekannte Positionen von Bryan Supran
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Direktor/Vorstandsmitglied | 31.07.2019 | 18.07.2022 |
VIATRIS INC. | Direktor/Vorstandsmitglied | - | 16.11.2020 |
ARRAY TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 30.07.2019 | - |
Corporate Officer/Principal | 30.07.2019 | - | |
MEDIVATION INC | Direktor/Vorstandsmitglied | 28.09.2016 | - |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 6 |
Corporate Officer/Principal | 1 |
General Counsel | 1 |
Sektoral
Health Technology | 6 |
Finance | 2 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PFIZER, INC. | Health Technology |
VIATRIS INC. | Health Technology |
HALEON PLC | Distribution Services |
Private Unternehmen | 4 |
---|---|
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Finance |
- Börse
- Insiders
- Bryan Supran
- Erfahrung